Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Upstream HPG Axis Modulation vs Exogenous Replacement

Exogenous testosterone. Whether cypionate, enanthate, or undecanoate esters. Suppresses endogenous production through negative feedback inhibition. When synthetic testosterone binds to androgen receptors in the hypothalamus and pituitary, LH and FSH secretion

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Exogenous testosterone. Whether cypionate, enanthate, or undecanoate esters. Suppresses endogenous production through negative feedback inhibition. When synthetic testosterone binds to androgen receptors in the hypothalamus and pituitary, LH and FSH secretion drops to near-zero within 4–8 weeks, and testicular testosterone production ceases. Testicular volume decreases by 25–40% within six months, and spermatogenesis becomes severely impaired or halted entirely. This is why fertility preservation requires discontinuation and post-cycle therapy.
  • Peptides targeting the HPG axis work differently. Kisspeptin, a 54-amino-acid peptide encoded by the KISS1 gene, stimulates gonadotropin-releasing hormone (GnRH) neurons in the hypothalamus. GnRH then signals the anterior pituitary to release LH and FSH in pulsatile fashion. The same physiological pattern that drives natural testosterone production. A 2024 Phase 2 trial at Imperial College London demonstrated that kisspeptin-54 administration increased LH pulse frequency by 300% and serum testosterone by 42% from baseline in hypogonadotropic hypogonadism patients without suppressing endogenous pulsatility.
  • Growth hormone secretagogues like MK-677 (ibutamoren) elevate growth hormone (GH) and insulin-like growth factor 1 (IGF-1), which modulate Leydig cell sensitivity to LH. Research from the University of Virginia published in The Journal of Clinical Endocrinology & Metabolism found that MK-677 at 25mg daily increased IGF-1 by 89% and free testosterone by 18% in aging men. Modest but achieved without HPG axis suppression.
  • Thymic peptides like Thymalin, a bioregulator peptide extracted from calf thymus, demonstrate immune-endocrine crosstalk effects. The thymus produces peptides that influence cytokine signalling and hypothalamic function. A 2023 Russian clinical study found Thymalin improved bioavailable testosterone by 14% in men over 50, likely through reduced inflammatory cytokine interference with GnRH pulsatility.